Clinical Trials in Detroit

Showing 9661-9680 of 19,719 trials

A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

NCT04414618

This proof of concept study will take place in the US and other countries in approximately 15 clinical sites and will enroll about 40 hospitalized patients diagnosed with COVID-19 infection who have developed pneumonia and require supplemental oxygen. 20 patients will receive opaganib in addition to standard of care twice each day for 14 days. 20 will receive matching placebo in addition to standard of care unless the patient has been discharged from the hospital without requiring supplemental oxygen, in which case study drug will only be administered for 10 days. All participants will be followed up for 4 weeks after their last dose of study drug.

Coronavirus Infections

RedHill Biopharma Limited42 participantsStarted Jul 2020

Scottsdale, Arizona, United States • Miami, Florida, United States • Detroit, Michigan, United States +6 more locations

TERMINATEDPhase 3< 1 mile

Fetal Pulse Oximetry Trial (FOX)

NCT00098709

The purpose of this study is to determine if the information provided to the physician by a fetal pulse oximeter during labor will reduce the chances of a cesarean delivery.

Pregnancy

The George Washington University Biostatistics Center10,000 participantsStarted May 2002

Birmingham, Alabama, United States • Chicago, Illinois, United States • Detroit, Michigan, United States +10 more locations

A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

Fetal Pulse Oximetry Trial (FOX)

Find Trials by Condition in Detroit

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection

Feasibility and Efficacy of a Brief Mindfulness-Based Intervention SMOKING INTERVENTION VIA THE INTERNET

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children

Narcotic vs. Non-narcotic Pain Study Protocol

A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis

Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma

Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.

Adaptive COVID-19 Treatment Trial 2 (ACTT-2)

Adaptive COVID-19 Treatment Trial (ACTT)

A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis

Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy Participants

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy